Dishman Pharmaceuticals and Chemicals Ltd (DISH)

Dishman Pharmaceuticals and Chemicals Limited, together with its subsidiaries, provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. It offers contract services, including process research and active pharmaceutical ingredients (APIs) supply to support early phase clinical trials; process development and optimization; cGMP manufacture; and commercial supply services. The company also manufactures and markets bulk drugs, intermediates, quaternary ammonium compounds (Quats), specialty chemicals, and outsourced/traded goods. In addition, it offers a range of vitamin D2, vitamin D3, and vitamin D analogues; cholesterol and lanolin related products for pharmaceutical, cosmetic, and related markets; and phase transfer catalysts, ammonium and phosphonium highpurity solid Quats, phosphoranes, and wittig reagents used as phase transfer catalysts, personal care ingredients, fine chemicals, pharma intermediates, and disinfectants. Further, the company provides a range of antiseptics and disinfectants, including disinfectants for surgical instrumentation, hand and body wash sanitizers and antiseptics, pre and post-operative surgical scrubs, and antimicrobial washes for healthcare and related industries. Dishman Pharmaceuticals and Chemicals Limited was incorporated in 1983 and is headquartered in Ahmedabad, India.